These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2466056)

  • 21. Clinical effects and pharmacokinetics of a single oral dose of pirmenol hydrochloride.
    Atarashi H; Kuruma A; Ino T; Hirayama Y; Saitoh H; Hayakawa H
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):556-62. PubMed ID: 8847873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pirmenol on premature atrial complexes.
    Toivonen LK
    Ann Clin Res; 1986; 18(2):106-8. PubMed ID: 3521442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic effects of pirmenol and lidocaine: a placebo-controlled, double-blind, comparative study.
    Nieminen MS; Toivonen L; Manninen V; Frick H
    Am J Cardiol; 1987 Jun; 59(16):27H-32H. PubMed ID: 3296728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of pirmenol enantiomers in coronary artery ligated dogs.
    Janiczek N; Smith DE; Chang T; Ventura A; Mertz TE
    J Pharm Sci; 1997 Apr; 86(4):443-9. PubMed ID: 9109046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of pirmenol administration on the anti-coagulant activity of warfarin.
    Stringer KA; Switzer DF; Abadier R; Lebsack ME; Sedman A; Chrymko M
    J Clin Pharmacol; 1991 Jul; 31(7):607-10. PubMed ID: 1894756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias.
    Liem LB; Clay DA; Franz MR; Swerdlow CD
    Am Heart J; 1987 Jun; 113(6):1390-6. PubMed ID: 3591608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and efficacy of pirmenol hydrochloride in the treatment of ventricular dysrhythmia.
    Lee TG; Goldberg AD; Chang T; Serkland MT; Yakatan GJ; Johnson EL; Toole JG; Goldstein S
    J Cardiovasc Pharmacol; 1983; 5(4):632-7. PubMed ID: 6193362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacology and pharmacokinetics of pirmenol.
    Reiter MJ
    Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary study of pirmenol in the treatment of ventricular arrhythmias.
    Gimeno Gascon JV; Algarra Vidal FJ
    Am J Cardiol; 1987 Jun; 59(16):53H. PubMed ID: 3591713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pirmenol in the long-term treatment of chronic ventricular arrhythmias: a placebo-controlled study.
    Toivonen LK; Nieminen MS; Manninen V; Frick MH
    J Cardiovasc Pharmacol; 1986; 8(1):156-60. PubMed ID: 2419679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia.
    Miura DS; Schwartz J; Laux B; Wynn J; Keefe D; Somberg JC
    J Clin Pharmacol; 1987 Jul; 27(7):481-6. PubMed ID: 3654999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
    Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
    Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias.
    Hampton EM; Anderson JL; Lutz JR; Nappi JM
    Eur J Clin Pharmacol; 1986; 31(1):15-22. PubMed ID: 3780822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of pirmenol in young and elderly subjects.
    Ferry DG; Campbell AJ; Bland R; Beasley M; Gazeley L; Edwards IR
    Eur J Clin Pharmacol; 1992; 43(4):437-9. PubMed ID: 1451728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics.
    Page RL; Wharton JM; Wilkinson WE; Friedman IM; Claypool WD; Karim A; Kowalski KG; McDonald SJ; Gardiner P; Pritchett EL
    Clin Pharmacol Ther; 1992 Apr; 51(4):371-8. PubMed ID: 1563207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral flecainide acetate for the treatment of ventricular arrhythmias.
    Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B
    N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of recainam, a new antiarrhythmic drug, for control of ventricular arrhythmias.
    Anderson JL; Anastasiou-Nana MI; Heath BM; Menlove RL; Nanas JN; Friedman J
    Am J Cardiol; 1987 Aug; 60(4):281-7. PubMed ID: 2441587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of pirmenol, a new antiarrhythmic agent, assessed noninvasively.
    Toivonen LK; Nieminen MS
    Int J Cardiol; 1986 Feb; 10(2):111-8. PubMed ID: 3943931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized double-blind placebo controlled crossover trial documenting oral lorcainide efficacy in suppression of symptomatic ventricular tachyarrhythmias.
    Keefe DL; Peters F; Winkle RA
    Am Heart J; 1982 Apr; 103(4 Pt 1):511-8. PubMed ID: 7039282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.